Comprehensive Safety Monitoring of 12-Month Daily 7000-IU Vitamin D3 Supplementation in Human Immunodeficiency Virus-Infected Children and Young Adults

Journal of Parenteral and Enteral Nutrition

Volumn 40, Issue 7, 2016, Pages 1057-1063

  Schall, Joan I ^a   Hediger, Mary L ^a   Zemel, Babette S ^a,b   Rutstein, Richard M ^a,b   Stallings, Virginia A ^a,b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

children; HIV infection; metabolic outcomes; safety; Vitamin D; young adults

Indexed keywords

25 HYDROXYVITAMIN D; ALBUMIN; CALCIUM; COLECALCIFEROL; CREATININE; EFAVIRENZ; GLUCOSE; PHOSPHORUS; PLACEBO; PROTEINASE INHIBITOR; C REACTIVE PROTEIN; CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ADULT; ADULT DISEASE; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; CALCIUM BLOOD LEVEL; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEMOGRAPHY; DRUG SAFETY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PHOSPHATE BLOOD LEVEL; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TREATMENT DURATION; URINALYSIS; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; YOUNG ADULT; ADOLESCENT; BLOOD; DIETARY SUPPLEMENT; DOSE RESPONSE; METABOLISM;

ADOLESCENT; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CALCIUM; CHILD; CHOLECALCIFEROL; CHOLESTEROL; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HIV INFECTIONS; HUMANS; INSULIN; MALE; TRIGLYCERIDES; YOUNG ADULT;

EID: 84982126075     PISSN: 01486071     EISSN: 19412444     Source Type: Journal    
DOI: 10.1177/0148607115593790     Document Type: Article

References (16)

1. Gröber U, Spitz J, Reichrath J, Kisters K, Holick MF,. Vitamin D: update 2013. From rickets prophylaxis to general preventive healthcare. Dermatoendocrinol. 2013; 5 (3): 331-347.
2. 3 supplementation in children and young adults with HIV: a randomized, placebo-controlled trial. Pediatr Infect Dis J. 2015; 34: e32-e40.
3. Chun RF, Liu NQ, Lee T, et al. Vitamin D supplementation and antibacterial immune responses in adolescents and young adults with HIV/AIDS. J Steroid Biochem Mol Biol. 2015; 148: 290-297.
4. Institute of Medicine. Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: National Academies Press; 2011.
5. Vogiatzi MG, Jacobson-Dickman E, DeBoer MD, for the Drugs and Therapeutics Committee of The Pediatric Endocrine Society. Vitamin D supplementation and risk of toxicity in pediatrics: a review of current literature. J Clin Endocrinol Metab. 2014; 99: 1132-1141.
6. Vieth R,. Implications for 25-hydroxyvitamin D testing of public health policies about the benefits and risks of vitamin D fortification and supplementation. Scand J Clin Lab Invest Suppl. 2012; 243: 144-153.
7. Heaney RP, Davies KM, Chen TC, Holick MF, barger-Lux MJ,. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr. 2003; 77: 204-210.
8. Heaney RP,. Vitamin D: criteria for safety and efficacy. Nutr Rev. 2008; 66: S178-S181.
9. Ng K, Scott JB, Drake BF, et al. Dose response to vitamin D supplementation in African Americans: results of a 4-arm, randomized, placebo-controlled trial. Am J Clin Nutr. 2014; 99 (3): 587-598.
10. Wu AH,. Tietz Clinical Guide to Laboratory Tests. 4th ed. St Louis, MO: W B Saunders Co; 2006.
11. 3 supplementation in children and young adults infected with human immunodeficiency virus. J Ped Infect Dis. 2014; 3: 294-230.
12. Groleau V, Herold RA, Schall JI, et al. Blood lead concentration is not altered by high-dose vitamin D supplementation in children and young adults with HIV. J Pediatr Gastroenterol Nutr. 2013; 56 (3): 316-319.
13. Arpadi SM, McMahon D, Abrams EJ, et al. Effect of bimonthly supplementation with oral cholecalciferol on serum 25-hydroxyvitamin D concentrations in HIV-infected children and adolescents. Pediatrics. 2009; 123: e121-e126.
14. 3 supplementation doses for children and adolescents. Pediatr Res. 2015; 77: 370-375.
15. Orkin C, Wohl DA, Williams A, Deckx H,. Vitamin D deficiency in HIV: a shadow on long-term management? AIDS Rev. 2014; 16: 59-74.
16. Portilla J, Moreno-Pérez O, Serna-Candel C, et al. Vitamin D insufficiency and subclinical atherosclerosis in non-diabetic males living with HIV. J Int AIDS Soc. 2014; 17: 18945.